Showing results (1-10 of 633) with videos related to
Sort By:
Pageof 64
Revue Medicale De Liege|June 5, 2020
[A revolution in the management of type 2 diabetes : antidiabetic agents providing a cardiovascular and renal protection independently of glucose control !]A J Scheen, N PaquotRevue Medicale De Liege|June 7, 2011
[Therapeutic approaches to improve blood glucose control in a patient with type 2 diabetes on a metformin-sulfonylurea combination]A J Scheen, N PaquotRevue Medicale De Liege|May 13, 2011
[Clinical vignette. Which combination of oral glucose-lowering agents to use after failure of metformin monotherapy in type 2 diabetes?]A J Scheen, N PaquotRevue Medicale De Liege|January 6, 2016
[TECOS: confirmation of the cardiovascular safety of sitaliptin]A J Scheen, N PaquotRevue Medicale De Liege|August 28, 2003
[Prevention of cardiovascular disease in type 2 diabetes]N Paquot, A J ScheenRevue Medicale De Liege|June 26, 2001
[Beneficial effects of physical activity on cardiovascular risk factors]A J Scheen, N PaquotRevue Medicale De Liege|January 9, 2014
[Rationale supporting basal insulin-incretin combined therapies in type 2 diabetes]A J Scheen, N PaquotRevue Medicale De Liege|August 16, 2012
[Type 2 diabetes: journey in the heart of a complex disease]A J Scheen, N PaquotRevue Medicale De Liege|May 8, 2009
[Vildagliptin (Galvus) and fixed combination vildagliptine-metformin (Eucreas) in the treatment of type 2 diabetes]A J Scheen, N PaquotPageof 64